Abstracts

  • Felice Petraglia, Alberto Imperatore, John R. G. Challis
    Neuroendocrine Mechanisms in Pregnancy and Parturition
    Endocr Rev 31: 783-816, 2010

  • Renato Pasquali, Alessandra Gambineri, Carla Cavazza, Daniela Ibarra Gasparini, Walter Ciampaglia, Graciela Estela Cognigni, Uberto Pagotto


    Heterogeneity in the responsiveness to long-term lifestyle intervention and predictability in obese women with polycystic ovary syndrome


    European Journal of Endocrinology, 164:53-60, 2011

  • Natsuko Tokushige, Robert Markham, Ben Crossett, Seong B. Ahn, Vidya L. Nelaturi, Alamgir Khan, Ian S. Fraser

    Discovery of a novel biomarker in the urine in women with endometriosis


    Fertil Steril 2011;95: 46–9

  • James D. M. Nicopoullos, Hossam Abdalla

    Poor response cycles: when should we cancel? Comparison of outcome between egg collection, intrauterine insemination conversion, and follow-up cycles after abandonment

    Fertil Steril 2011;95:68–71

  • Brian W. Whitcomb, Renee Turzanski-Fortner, Kevin S. Richter, Simon Kipersztok, Robert J. Stillman, Michael J. Levy, Eric D. Levens


    Contribution of male age to outcomes in assisted reproductive technologies

    Fertil Steril 2011;95:147–51

  • TAREK GELBAYA, SRISAILESH VITTHALA, LUCIANO NARDO, MORAD SEIF

    Optimizing hormone therapy for future reproductive performance in women with premature ovarian failure

    Gynecological Endocrinology, 2011; 27(1): 1–7

  • Ilana J. Halperin, Shoba Sujana Kumar, Donna F. Stroup, Sheila E. Laredo

    The association between the combined oral contraceptive pill and insulin resistance, dysglycemia and dyslipidemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of observational studies


    Hum. Reprod. 201, 26(1): 191-201

  • Barbara Luke, Morton B. Brown, Judy E. Stern, Stacey A. Missmer, Victor Y. Fujimoto, Richard Leach


    Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates


    Hum. Reprod. 2011, 26(1): 245-252

  • Irene Lambrinoudaki

    Cardiovascular risk in postmenopausal women with the polycystic ovary Syndrome

    Maturitas 68: 13–16, 2011

  • Guy Leclercq, Patricia de Cremoux, Pascale This, Yves Jacquot
    Lack of sufficient information on the specificity and selectivity of commercial phytoestrogens preparations for therapeutic purposes

    Maturitas 68 (2011) 56–64

  • Karin Schenck-Gustafsson, Mark Brincat, Tamer Erel, Marco Gambacciani, Irene Lambrinoudaki, Mette H. Moen, Florence Tremollieres, Svetlana Vujovic Serge Rozenberg, Margaret Rees

    EMAS position statement: Managing the menopause in the context of coronary heart disease

    Maturitas 68: 94–97, 2011

  • Rogério Bonassi Machado, Luciano de Melo Pompei, Arícia Galvão Giribela, Cassiana Galvão Giribela

    Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits


    Women’s Health 7: 19–30, 2011

  • Victor W Henderson

    Gonadal hormones and cognitive aging: a midlife perspective


    Women’s Health 7: 81–93, 2011

  • Nicola Pluchino, Fiorella Bucci, Vito Cela, Alessandra Cubeddu, Andrea Riccardo Genazzani

    Menopause and mental well-being: timing of symptoms and timing of hormone treatment


    Women’s Health 7: 71–80, 2011

  • Santiago Palacios

    Hypoactive Sexual Desire Disorder and current pharmacotherapeutic options in women


    Women’s Health 7: 95–107, 2011